Search - Prime Therapeutics

457 Results for GLP-1 Pipeline Update

Prime Therapeutics to retain Humira® alongside biosimilars on NetResults™ formulary in 2023

Lowest net cost strategy helps enable provider, patient choice; helps ensure optimal, cost-effective therapy for complex inflammatory conditions.

PA Sub-Categories: Specialty drugs Prime Article: Press Releases
Prime’s managed care residency offers firsthand understanding of medical and pharmacy integration

Upcoming webinar on Nov. 6 shares more about Prime’s industry-leading ASHP-accredited PGY1 residency program

Prime Article: Stories
Device Return

Computer return instructions Congratulations! You've received a new computer from Prime. When you're ready to transition to your new device, here are the steps to follow. Don't lose your data! To...
TOP$

Get TOP$ support We administer the TOP$ multistate Medicaid pharmaceutical purchasing pool, helping states save big. Breadcrumb Home Our solutions Government solutions State government solutions...